Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis Mariette Baud, MD, Salvatore Strano, MD, PhD, Agnes.

Slides:

Advertisements

Similar presentations

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

Mitral stenosis with pulmonary hypertension: We should operate early

Sotiris C. Stamou, MD, PhD, Michael Robich, MD, MSPH, Robert E

Christine Jablonski, M. D. , Marco Alifano, M. D

Preresection serum C-reactive protein measurement and survival among patients with resectable non–small cell lung cancer Marco Alifano, MD, PhD, Pierre.

Which patients should be operated on after induction chemotherapy for N2 non–small cell lung cancer? Analysis of a 7-year experience in 175 patients

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

Lobectomy with pulmonary artery resection: Morbidity, mortality, and long-term survival Marco Alifano, MD, Giacomo Cusumano, MD, Salvatore Strano, MD,

Body Mass Index and Total Psoas Area Affect Outcomes in Patients Undergoing Pneumonectomy for Cancer Remi Hervochon, MD, Antonio Bobbio, MD, PhD, Claude.

John E. Pilling, FRCS (CTh), Michael E

Intrinsic cardiac stem cells are essential for regeneration

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

Multilevel data analysis: What? Why? How?

Outcomes in lung transplantation after previous lung volume reduction surgery in a contemporary cohort Leah Backhus, MD, Jonathon Sargent, BS, Aaron.

How should we treat air leaks?

Go on-pump or off-pump in diabetic patients?

What is the best approach for surgery of malignant pleural mesothelioma? It is to put our efforts into obtaining trustworthy evidence for practice Tom.

One-year results of thoracic endovascular aortic repair for blunt thoracic aortic injury (RESCUE trial) Ali Khoynezhad, MD, PhD, FACS, Carlos E. Donayre,

The lord of the rings Antonio Miceli, MD, PhD

The variability of the mitral valve anatomy and terminology

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Military surgeons just want to have fun

A first start for lung transplantation?

Arterial lactate before initiation of venoarterial extracorporeal membrane oxygenation for postcardiotomy shock improves postimplant outcome prediction

Stephen R. Broderick, MD, MPHS

Shawn S. Groth, MD, MS, R. Taylor Ripley, MD, Bryan M. Burt, MD

Commentary: “Proceed to and follow the highlighted route”—Thoracic surgical Waze is here Moishe Liberman, MD, PhD The Journal of Thoracic and Cardiovascular.

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

The Journal of Thoracic and Cardiovascular Surgery

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Impact of low donor to recipient weight ratios on cardiac transplantation Senthil Nathan Jayarajan, MD, Sharven Taghavi, MD, Eugene Komaroff, PhD, Abeel.

Historical perspectives of The American Association for Thoracic Surgery: Robert M. Janes, MD ( ) Myunghyun Lee, MD, Vivek Rao, MD, PhD The.

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: Implications for revision of the.

Attachment disorder in thoracoabdominal surgery

Manuel J. Antunes, MD, PhD, DSc

Commentary: Do the right thing! Ethical versus legal

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Patients with unbalanced atrioventricular canal defects can undergo the Fontan operation with good outcomes Sitaram M. Emani, MD The Journal of Thoracic.

Innovation in cardiothoracic surgical training

First nights, the adrenal axis, and steroids

The American Association for Thoracic Surgery 2016 ethics forum: Working virtues in surgical practice Larry R. Churchill, PhD The Journal of Thoracic.

Positron emission tomography predicts survival in malignant pleural mesothelioma Raja M. Flores, MD, Timothy Akhurst, MD, Mithat Gonen, PhD, Maureen Zakowski,

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Commentary: “Isn't cardiac surgery a team sport?”

The continuing challenge of congenital heart disease in China

Raja M. Flores, MD The Journal of Thoracic and Cardiovascular Surgery

Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD

Therapeutic R2 resection for pleural mesothelioma

“The more things change…”: The challenges ahead

Why arch curvature affects arch resistance

Evaluating the best approach to treatment of aortic stenosis: The jury is still out Glen B. Taksler, PhD The Journal of Thoracic and Cardiovascular Surgery

Apples remain apples NO matter what

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Preoperative PFTs: The answer is blowing in the wind

The evolution of cardiothoracic critical care

Carcinoma showing thymus-like elements invading the trachea

Did you like Terminator 3 better than Terminator 2

Kalpaj Parekh, MD, Bryan F. Meyers, MD, G

How do we follow up our patients

Journal changes and initiatives

Deciding how much to pay for effective care

Presentation transcript:

Outcome and prognostic factors of pleural mesothelioma after surgical diagnosis and/or pleurodesis Mariette Baud, MD, Salvatore Strano, MD, PhD, Agnes Dechartres, MD, Rami Jouni, MD, Frederic Triponez, MD, PhD, Christos Chouaid, MD, PhD, Patricia Forgez, PhD, Diane Damotte, MD, PhD, Nicolas Roche, MD, PhD, Jean-François Régnard, MD, Marco Alifano, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 145, Issue 5, Pages 1305-1311 (May 2013) DOI: 10.1016/j.jtcvs.2012.09.023 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Flow diagram of patients. MPM, Malignant pleural mesothelioma. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1305-1311DOI: (10.1016/j.jtcvs.2012.09.023) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 A, Kaplan-Meier overall survival of the whole population. B, Kaplan-Meier overall survival with respect to gender. C, Kaplan-Meier overall survival with respect to asbestos exposure. D, Kaplan-Meier overall survival with respect to American Society of Anesthesiologists (ASA) class. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1305-1311DOI: (10.1016/j.jtcvs.2012.09.023) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 A, Kaplan-Meier overall survival with respect to histologic type. B, Kaplan-Meier overall survival with respect to blood leukocyte count. C and D, Kaplan-Meier overall survival with respect to C-reactive protein (CRP) levels.WBC, White blood cells. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1305-1311DOI: (10.1016/j.jtcvs.2012.09.023) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions